Skip to main content

China COVID cases could double next month, as Merck antiviral gets approval

China's health service approved an antiviral to treat COVID-19 as one health company estimates the country will see a doubling of its current wave of cases.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.